| Absorption |
| Blood-Brain Barrier | BBB+ | 0.5000 |
| Human Intestinal Absorption | HIA+ | 0.9860 |
| Caco-2 Permeability | Caco2+ | 0.6931 |
| P-glycoprotein Substrate | Substrate | 0.6548 |
| P-glycoprotein Inhibitor | Inhibitor | 0.7442 |
| Non-inhibitor | 0.7372 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9135 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7988 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8320 |
| CYP450 2D6 Substrate | Non-substrate | 0.8869 |
| CYP450 3A4 Substrate | Substrate | 0.6811 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9253 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8936 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9140 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8316 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8345 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8676 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9894 |
| Non-inhibitor | 0.8737 |
| AMES Toxicity | Non AMES toxic | 0.8689 |
| Carcinogens | Non-carcinogens | 0.8257 |
| Fish Toxicity | High FHMT | 0.8784 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9534 |
| Honey Bee Toxicity | High HBT | 0.7703 |
| Biodegradation | Not ready biodegradable | 0.9544 |
| Acute Oral Toxicity | III | 0.6658 |
| Carcinogenicity (Three-class) | Non-required | 0.5877 |